Vitrolife’s Board has today appointed Thomas Axelsson as the new CEO of Vitrolife. Thomas has been working as the Acting CEO of the Group since November 2011.
Thomas Axelsson has broad experience and has displayed successful leadership and is the choice of the Board for the position of CEO after a thorough recruitment process where Thomas has competed with a number of other strong candidates. “Thomas has learnt about Vitrolife’s business in a short period of time and established appreciated leadership. Thomas’ broad experience from the medical device area will enrich the organization and we look forward to continuing our successful expansion under Thomas’ leadership,” says Patrik Tigerschiöld, Chairman of Vitrolife’s Board.
“I have had the privilege of becoming acquainted with this successful company for a number of months now and look forward with great confidence to the opportunities that we see for continued expansive development. Vitrolife has an organization that runs smoothly, with very competent co-workers and together we will strengthen Vitrolife’s global position”, says Thomas Axelsson.
April 18, 2012
VITROLIFE AB (publ)
Queries should be addressed to:
Patrik Tigerschiöld, Chairman of the Board, phone 46 8 614 00 20
Vitrolife is required to publish the information in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on April 18, at 2 p.m.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.